Denovo Biopharma Receives US FDA Fast Track Design...
Category : ODD/BTA/FTA Status 14 October 2024Denovo Biopharma receives US FDA fast track designation for its liafensine for treating patients wit...
Denovo Biopharma receives US FDA fast track designation for its liafensine for treating patients wit...
Overview Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary smal...
FDA Grants Fast Track Designation For Biomarker-Guided DB104 (liafensine) in Patients with Treatment...
Boehringer gets US FDA breakthrough therapy designation and initiates two phase III trials in MASH f...
Overview PTC Therapeutics announced that the FDA has granted Fast Track designation to the PTC518...